There has been an increase in Risk Sharing Schemes for pharmaceuticals both in healthcare institutions and pharmaceutical companies in Europe in recent years as an additional approach to provide continuous comprehensive and fair healthcare.

The success of a performance-based scheme needs to be measured, documented and evaluated. 

Whether you are a payer or a pharmaceutical company you have the same interest in making sure that the risk sharing scheme outcome is evaluated by an independent and neutral third party.

Qsee is the independent service provider of choice for the monitoring and auditing of outcomes in Risk Sharing Schemes.